Positioning political selling, disclosed 2026-10-01
Options no verdict drawn today, left as found
Ethical screen not yet scored
Price61.14 USD
Fair value50.37
Ethical score70.0/100
Our investment reviews on this name
2026-07-02Read Markup61.14+0.0% to today ✓First review on file: Markup
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
Thermon Group Holdings, Inc. holds its Markup at $61.14. The statistical read favours the sellers, held for 1 days.
As held on the ledger · 2026-07-19
Phase
Markup
Quantitative state
The statistical read favours the sellers, held for 1 days
Price at the screen
$61.14
Valuation
44.96 trailing · 24.59 forward price to earnings
Values screen
Not scored· score 70.0
Beta
0.83
The Workings
Five Screens, Shown in Full
This security has not been fully scored against the values screen yet.
Test
Figure
Limit
What it means
Status
Business activity
Permissible
Core business clean
Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending.
Pass
Debt load
Excluded
Below 33%
Interest-bearing debt is of its assets, above the one-third ceiling the screen allows.
Fail
Interest-bearing cash
Excluded
Below 33%
Interest-bearing cash and securities are of assets, above the one-third limit.
Fail
Receivables
Excluded
Below 49%
Money owed to the company is of assets, above the 49% limit.
Fail
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
The Ethical Read
The Read, in Plain English
Thermon Group Holdings, clears the business-activity screen and the figures we can measure look clean, but one or more financial figures are still pending, so the verdict is not final yet.
Read as at 2026-10-27. It updates when the underlying figures move, and past reads are kept below.
Fair value range in USD, drawn from the 2026-07-19 screen. The gold marker is the market price at the same screen. The price runs 17.6% above the base estimate.
Reading the gap · Both our model and the Street see limited upside at this price.
Price History & Projections
Where it has been, where the models see it going. History from market close data; projection points are our fair-value estimates and third-party analyst targets, dated to the 2026-07-19 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain Words
Industrial Heating Stock Priced Far Beyond Its Worth
Thermon makes the heating systems that keep pipes and tanks flowing in factories from Texas to the Middle East. Yet the shares sit at $61 against a fair value near $50, leaving investors paying a stiff premium for steady but unspectacular kit. With a 24.6 times forward earnings multiple, single-digit profit margins and a 9 percent return on equity, the valuation leaves little room for the modest 11 percent revenue growth on offer.
We pass because the numbers do not justify the price. Three analysts see fair value around $51 and rate the shares a hold. The business clears our ethical screen, yet that alone cannot offset an 18 percent gap between market price and our assessment of intrinsic worth.
Cyclical demand in process industries adds further uncertainty. Any slowdown in energy or chemicals projects would quickly expose the thin margin of safety now baked into the share price. Analysis, not advice.
The risks · The main risks here are ordinary market swings and the chance our fair-value read proves too optimistic.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to Trade
THR trades on the NYSE. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
The Dated Journal · Newest First, Never Edited
Every Entry, As Written
2026-10-23Markup$61.14+0.0%Entry 7
The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 62% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 131%. Our forward projection puts the odds of a 10% gain over the next month near 32%. The street (3 analysts) rates it hold, with a mean price target of $51.
2026-10-02Markup$61.14+0.0%Entry 6
Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 62% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 131%. Our forward projection puts the odds of a 10% gain over the next month near 32%. The street (3 analysts) rates it hold, with a mean price target of $51.
2026-09-14Markup$61.14+0.0%Entry 5
Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 62% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 131%. Our forward projection puts the odds of a 10% gain over the next month near 32%. The street (3 analysts) rates it hold, with a mean price target of $51.
2026-08-14Markup$61.14+0.0%Entry 4
Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 62% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 131%. Our forward projection puts the odds of a 10% gain over the next month near 32%. The street (3 analysts) rates it hold, with a mean price target of $51.
2026-07-18Markup$61.14+0.0%Entry 3
Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 62% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 131%. Our forward projection puts the odds of a 10% gain over the next month near 32%. The street (3 analysts) rates it hold, with a mean price target of $51.
2026-07-03Markup$61.14+0.0%Entry 2
Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows excellent risk-adjusted returns.
2026-07-02Markup$61.14Entry 1
Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows excellent risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
